Tracking Virginia’s General Assembly
since 2007.
HJ79: Physicians, etc.; barring from prescribing an alternative brand of medicine for financial incentive.
WHEREAS, across the United States, physicians and patients are often encouraged to switch medicines based on cost considerations; and
WHEREAS, the best treatment option for each individual should be the primary concern for physicians and other health practitioners in determining such treatment options, including prescriptive medications; and
WHEREAS, FDA-approved generics are safe and effective and often represent an opportunity for much-needed health care cost savings; and
WHEREAS, patients assume that physicians and other health practitioners authorized to prescribe medications base treatment decisions, including decisions regarding prescription of medication, on their clinical expertise and ethical guidelines; and
WHEREAS, the patient-health practitioner relationship relies on the confidential, honest, and transparent exchange of information; and
WHEREAS, physicians or health practitioners receiving
financial incentives to prescribe certain medications violate that relationship
when patients are not informed of said practitioner's financial incentives [ ;
and
WHEREAS, the National Conference of Insurance Legislators
hereby recognizes that patients should be notified by their prescribing
physicians or health practitioner if said physician or health practitioner
receives financial compensation for the interchange or substitution of
therapeutic or generic medication ] ; now, therefore, be it
RESOLVED by the House of Delegates, the Senate concurring, That the Governor and the Secretary of Health and Human Resources be requested to implement a policy barring physicians or other health care practitioners from prescribing an alternative brand of medication because of financial incentives offered to the physician or other health care practitioner without first disclosing the incentives offered to the patient or the patient's parent, legal guardian, or other authorized representative.
The Governor and the Secretary of Health and Human Resources shall submit to the Division of Legislative Automated Systems an executive summary and report of its progress in meeting the request of this resolution no later than the first day of the 2009 Regular Session of the General Assembly. The executive summary and report shall be submitted for publication as a report document as provided in the procedures of the Division of Legislative Automated Systems for the processing of legislative documents and reports and shall be posted on the General Assembly's website.
WHEREAS, across the United States, physicians and patients are often encouraged to switch medicines based on cost considerations; and
WHEREAS, the best treatment option for each individual should be the primary concern for physicians and other health practitioners in determining such treatment options, including prescriptive medications; and
WHEREAS, FDA-approved generics are safe and effective and often represent an opportunity for much-needed health care cost savings; and
WHEREAS, patients assume that physicians and other health practitioners authorized to prescribe medications base treatment decisions, including decisions regarding prescription of medication, on their clinical expertise and ethical guidelines; and
WHEREAS, the patient-health practitioner relationship relies on the confidential, honest, and transparent exchange of information; and
WHEREAS, physicians or health practitioners receiving financial incentives to prescribe certain medications violate that relationship when patients are not informed of said practitioner's financial incentives; and
WHEREAS, the National Conference of Insurance Legislators hereby recognizes that patients should be notified by their prescribing physicians or health practitioner if said physician or health practitioner receives financial compensation for the interchange or substitution of therapeutic or generic medication; now, therefore, be it
RESOLVED by the House of Delegates, the Senate concurring, That the Governor and the Secretary of Health and Human Resources be requested to implement a policy barring physicians or other health care practitioners from prescribing an alternative brand of medication because of financial incentives offered to the physician or other health care practitioner without first disclosing the incentives offered to the patient or the patient's parent, legal guardian, or other authorized representative.
The Governor and the Secretary of Health and Human Resources shall submit to the Division of Legislative Automated Systems an executive summary and report of its progress in meeting the request of this resolution no later than the first day of the 2009 Regular Session of the General Assembly. The executive summary and report shall be submitted for publication as a report document as provided in the procedures of the Division of Legislative Automated Systems for the processing of legislative documents and reports and shall be posted on the General Assembly's website.
Additional Data
Explanation
This is the actual text of the bill — the legislation itself. Generally this is amending existing law, proposing the addition or removal of words from laws that are already on the books.
Words that are highlighted in yellow are
proposed additions, and words that are crossed out in
red are proposed removals.
The numbers with the § symbol before them are references to existing laws, and if you click on them they’ll take you to that part of the law on the state's website.
